|
|
Volumn 31, Issue 2, 2013, Pages
|
|
Case report
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AXITINIB;
BEVACIZUMAB;
ETHAMBUTOL;
INTERFERON;
ISONIAZID;
PYRAZINAMIDE;
RIFAMPICIN;
SORAFENIB;
TEMSIROLIMUS;
ANTINEOPLASTIC AGENT;
DRUG DERIVATIVE;
IMIDAZOLE DERIVATIVE;
INDAZOLE DERIVATIVE;
MONOCLONAL ANTIBODY;
RAPAMYCIN;
ADULT;
ARTICLE;
BONE METASTASIS;
CANCER CHEMOTHERAPY;
CASE REPORT;
COMPUTER ASSISTED TOMOGRAPHY;
DISEASE COURSE;
DRUG WITHDRAWAL;
FLANK PAIN;
HUMAN;
KIDNEY CARCINOMA;
LUNG LAVAGE;
LUNG NODULE;
LUNG TUBERCULOSIS;
MALE;
MYCOBACTERIUM TUBERCULOSIS;
NEPHRECTOMY;
PRIORITY JOURNAL;
THORAX RADIOGRAPHY;
TREATMENT DURATION;
TREATMENT RESPONSE;
KIDNEY TUMOR;
MICROBIOLOGY;
MIDDLE AGED;
PHASE 3 CLINICAL TRIAL (TOPIC);
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TUBERCULOSIS;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS, PHASE III AS TOPIC;
HUMANS;
IMIDAZOLES;
INDAZOLES;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SIROLIMUS;
TUBERCULOSIS;
|
|
EID: 84872471691
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2012.43.7566 Document Type: Article |
|
Times cited : (6)
|
|
References (7)
|
